EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...
1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
In one of the most amusing citizen science projects we've ever come across, Australia's leading research agency the CSIRO is ...
Don't let "low testosterone" deprive you of the quality of your life. See your options (legal/non-prescription/safe).
Dr. Ajay Bakhshi, MD, a gastrointestinologist based in Maryland, points out that an IBS diagnosis is typically given when a ...
Four Purdue professors were recently appointed Showalter Faculty Scholars. The addition of Leifu Chang, Bruno Roseguini, ...
WHEN you’re struggling to go for a number two life can get seriously uncomfortable. Research by PrecisionBiotics has found ...
Future Market Insight projects that the global iron oxide market share will grow at a CAGR of 4.1% to reach USD 3,929.7 ...
A slice of Ezekiel bread has only 80 calories and is packed with micronutrients and macronutrients that will keep you full ...
After thousands of mysterious dark, sticky balls washed up on shorelines in Sydney, Australia in October – leading to beach ...
The first patent, "Process for production of a soluble and insoluble collagen product from mammalian dermis tissue", protects Humabiologics' unique method for producing both soluble and insoluble ...